Delivery Order SPE2DB20D2104-SPE2DB24FR91X
Award Date 1/4/24
Potential Completion Date 1/5/24
Potential Value $1.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,157.27 Firm Fixed Price Delivery Order is for the supply of LIALDA DR 1.2 GM TABLET 120S, a medication used to treat ulcerative colitis. The contract has an ultimate completion date of February 17, 2023 and was awarded on February 16, 2023. This contract is not designated as a set-aside and appears to be part...
- This federal contract award, with ID SPE2DX15D6028, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $97,264.05 firm fixed-price delivery order is for 4534482086 units of LIALDA 1.2GM 1440S, a pharmaceutical product. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans'...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,497.49, is for the supply of Lialda DR 1.2 GM Tablet 120S, a medication used to treat ulcerative colitis. The contract has a firm fixed price and an ultimate completion date of March 17, 2023. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,752.94 Firm Fixed Price delivery order is for the drug Lialda, a tablet used to treat ulcerative colitis. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $3,420.36 to Amerisourcebergen Drug Corporation for 120 tablets of 1.2 gm LIALDA DR, to be delivered from its Conshohocken, Pennsylvania facility by August 23, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation. The Defense Logistics Agency manages the Department of Defense's global logistics operations, including procuring and providing medical supplies to support the...
- This federal contract award is for the delivery of 120 tablets of 1.2 gram mesalamine delayed-release tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,286.56, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed-price delivery order type and an ultimate completion date of September 15, 2023. This contract is not designated as a set-aside procurement....
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,785.70, is a delivery order for MESALAMINE DR 1.2 GM TABLET 120S. The contract is a Firm Fixed Price award with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $12,221.22 firm fixed-price delivery order is for the supply of Mesalamine DR 1.2 GM tablets. The contract has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, valued at $2,959.37, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical division. The contract delivers MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price valued at $1,195.74. The contract is for the delivery of 120 tablets of the medication Mesalamine DR 1.2 GM to the Defense Logistics Agency, a defense agency. The contract has an ultimate completion date of June 5, 2025 and was awarded on June 4, 2025. The contract is not set aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...